# Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI

Study · id `cardio:ct-nct02590653` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02590653](<https://clinicaltrials.gov/study/NCT02590653>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02590653

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

## Technical summary

Registry record NCT02590653. Randomized; no masking; primary purpose treatment. Start 2014-10 (actual); primary completion 2019-12 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 200 participants (enrolled count; ClinicalTrials.gov record NCT02590653, source copy `cardio:ctgov-nct02590653-2020-03-24`, retrieved 2026-10-26)
- Started: 2014-10 (actual) (ClinicalTrials.gov record NCT02590653, source copy `cardio:ctgov-nct02590653-2020-03-24`, retrieved 2026-10-26)
- Primary completion: 2019-12 (actual) (ClinicalTrials.gov record NCT02590653, source copy `cardio:ctgov-nct02590653-2020-03-24`, retrieved 2026-10-26)
- Completion: 2020-02 (actual) (ClinicalTrials.gov record NCT02590653, source copy `cardio:ctgov-nct02590653-2020-03-24`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT02590653, source copy `cardio:ctgov-nct02590653-2020-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02590653-2020-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Assessment of the Effects of Atorvastatin Therapy on Myocardial Deformation Characteristics, in Patients With STEMI
- Acronym: CONTRAST
- Condition: Myocardial Infarction
- Intervention (Drug): Atorvastatin
- Lead sponsor: Penza State University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry intervention name matches this record: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Provenance

Content hash: 87d60a5a8ee54bfd17543b70514a56062b8b0fd7232e7b82cae1daaab4543606
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
